Biolife Solutions
(BLFS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 532 | 788 | 67 | 286 | 2,150 |
| Receivables | 75 | 1,907 | 45 | 54 | 80 |
| Inventories | 94 | 40 | N/A | 488 | 650 |
| Other current assets | 0 | 106 | 26 | 0 | 140 |
| TOTAL | $704 | $2,841 | $156 | $851 | $3,020 |
| Non-Current Assets | |||||
| PPE Net | 129 | 123 | 158 | 454 | 430 |
| Intangibles | 0 | 0 | 0 | 471 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 520 |
| TOTAL | $129 | $123 | $158 | $925 | $950 |
| Total Assets | $833 | $2,964 | $314 | $1,777 | $3,980 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 85 | 563 | 172 | 1,000 | 120 |
| Accrued Expenses | 135 | 339 | 351 | 466 | 220 |
| TOTAL | $220 | $1,608 | $868 | $1,466 | $360 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $220 | $1,608 | $868 | $1,466 | $360 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 886 | 886 | 886 | 886 | N/A |
| Common Shares | 12 | 12 | 12 | 12 | 10 |
| Retained earnings | -40,063 | -39,320 | -37,495 | -37,711 | -33,300 |
| Other shareholders' equity | 0 | 0 | -1,434 | 0 | 0 |
| TOTAL | $613 | $1,356 | $-554 | $311 | $3,620 |
| Total Liabilities And Equity | $833 | $2,964 | $314 | $1,777 | $3,980 |